The use of monoclonal antibodies as a way to prevent people from getting very sick with COVID-19 is rapidly increasing — alongside the grim statistics on surging infection rates across the country.
, South Carolina and North Carolina -- designated by HHS as Region 4 -- ordered about 198,000 patient courses, or roughly 45% of the national order.
The antibody treatment is meant for COVID-19 patients early in their infection and who are at high risk of getting even sicker, nipping infections in the bud before it puts people in the hospital. The drug can also now be used for preventative use in some cases. The Food and Drug Administration expanded Regeneron's authorization in late July, allowing for proactive prophylactic use for people who may have been exposed to COVID, and are at high risk of getting very sick because of health complications, being immunocompromised or because a person wasn't fully vaccinated.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Covid-19: Four more Covid-related deaths and 1,612 new casesThe total number of deaths linked to Covid-19 in NI since the start of the pandemic is now 2,291.
Consulte Mais informação »
Covid-19: Eleven more Covid-related deaths and 1,485 new casesThe total number of deaths linked to Covid-19 in NI since the start of the pandemic is now 2,302.
Consulte Mais informação »
Covid: Government warns Covid test firms over misleading pricesMore than 80 Covid test firms are issued with warnings and could be taken off the government's website.
Consulte Mais informação »
'Stop it': FDA warns people not to take veterinary drugs to treat COVID-19No form of the ivermectin drug has been approved by the FDA for use in treating or preventing COVID-19 in humans, the agency said.
Consulte Mais informação »
FDA Warns Against Using Livestock Drug To Treat COVID-19'You are not a horse. You are not a cow. Seriously, y'all. Stop it.'
Consulte Mais informação »